>Q13017_Disorder
4-17, 21-35, 507-511, 731-736, 964-1004, 1017-1050, 1069-1092, 1128-1149, 1189-1217, 1243-1258, 1343-1347, 1458-1490, 1495-1499
mmaKNKEPRP PSYTISIvgl SGTEKDKGNC GVGKSclcnr fvrskadeyy pehtsvlsti dfggrvvnnd hflywgdiiq nsedgvecki hvieqtefid dqtflphrst nlqpyikraa asklqsaekl myictdqlgl eqdfeqkqmp egklnvdgfl lcidvsqgcn rkfddqlkfv nnlfvqlsks kkpviiaatk cdecvdhylr evqafasnkk nllvvetsar fnvnietcft alvqmldktr skpkiipyld ayktqrqlvv tatdkfeklv qtvrdyhatw ktvsnklknh pdyeeyinle gtrkarntfs khieqlkqeh irkrreeyin tlprafntll pnleeiehln wsealklmek radfqlcfvv lektpwdetd hidkindrri pfdllstlea ekvyqnhvqh lisekrrvem kekfkktlek iqfispgqpw eevmcfvmed eaykyitead skevygrhqr eivekakeef qemlfehsel fydldlNATP Ssdkmseiht vlseepryka lqklapdres lllkhigfvy hptketclsg qnctdikveq llassllqld hgrlrlyhds tnidkvnlfi lgkdglaqel aneirtqstd deyaldgkiy eldlrpvdak spyflsqlwt aafkphgcfc vfnsieslsf igefigkirt easqirkdky manlpftlil anqrdsiskn lpilrhqgqq lanklqcpfv DVPAGTyprk fnetqikqal rgvlesvkhn ldvvspipan kdlseadlri vmcamcgdpf svdlilspfl dshscsaaqa gqnnslmldk iigekrrriq itilsyhssi gvrkdelvhg yilvysakrk asmgmlrafl sevqdtipvq lvavtdsqad ffeneaikel mtegehiate itakftalys lsqyhrqtev ftlffsdvle kknmiensyl sdntresthq sedVFLPSPR DCFPYNNYPD SDDDTEAPPP YSPIGDDVQL LPTPsdrsry rldlegNEYP IHSTPNCHDH ERNHKVPPPI KPKPVVPKTN vkkldpnllk tieagigkNP RKQTSRVPLA HPEDMDPSDN YAepidtifk qkgysdeiyv vpddsqnrik irnsfvnNTQ GDEENGFSDR TSKSHGERRp skykyksktl fskaksyyrr thsdasddea fttsktkrKG RHRGSEEDPL LSPVETWKGG IDNPAITsdq elddkkmkkk thkvkedkkq kkKTKNFNPP TRRNWESNyf gmplqdlvta ekpiplfvek cvefiedtgl cteglyrvsg nktdqdniqk qfdqdhninl vsmevtvnav agalkaffad lpDPLIPysl hpelleaaki pdkterlhal keivkkfhpv nydvfryvit hlnrvsqqhk inlmtadnls icfwptlmrp dfenreflst tkihqsvvet fiqqcqfffy ngeivetTNI VAPPPPSNPG QLVEPMVPLQ LPPPLQPQLI qpqlQTDPLg ii
>Q13017_GlobDoms
36-963, 1259-1457
mmaknkeprp psytisivgl sgtekdkgnc gvgksCLCNR FVRSKADEYY PEHTSVLSTI DFGGRVVNND HFLYWGDIIQ NSEDGVECKI HVIEQTEFID DQTFLPHRST NLQPYIKRAA ASKLQSAEKL MYICTDQLGL EQDFEQKQMP EGKLNVDGFL LCIDVSQGCN RKFDDQLKFV NNLFVQLSKS KKPVIIAATK CDECVDHYLR EVQAFASNKK NLLVVETSAR FNVNIETCFT ALVQMLDKTR SKPKIIPYLD AYKTQRQLVV TATDKFEKLV QTVRDYHATW KTVSNKLKNH PDYEEYINLE GTRKARNTFS KHIEQLKQEH IRKRREEYIN TLPRAFNTLL PNLEEIEHLN WSEALKLMEK RADFQLCFVV LEKTPWDETD HIDKINDRRI PFDLLSTLEA EKVYQNHVQH LISEKRRVEM KEKFKKTLEK IQFISPGQPW EEVMCFVMED EAYKYITEAD SKEVYGRHQR EIVEKAKEEF QEMLFEHSEL FYDLDLNATP SSDKMSEIHT VLSEEPRYKA LQKLAPDRES LLLKHIGFVY HPTKETCLSG QNCTDIKVEQ LLASSLLQLD HGRLRLYHDS TNIDKVNLFI LGKDGLAQEL ANEIRTQSTD DEYALDGKIY ELDLRPVDAK SPYFLSQLWT AAFKPHGCFC VFNSIESLSF IGEFIGKIRT EASQIRKDKY MANLPFTLIL ANQRDSISKN LPILRHQGQQ LANKLQCPFV DVPAGTYPRK FNETQIKQAL RGVLESVKHN LDVVSPIPAN KDLSEADLRI VMCAMCGDPF SVDLILSPFL DSHSCSAAQA GQNNSLMLDK IIGEKRRRIQ ITILSYHSSI GVRKDELVHG YILVYSAKRK ASMGMLRAFL SEVQDTIPVQ LVAVTDSQAD FFENEAIKEL MTEGEHIATE ITAKFTALYS LSQYHRQTEV FTLFFSDVLE KKNMIENSYL SDNTRESTHQ SEDvflpspr dcfpynnypd sdddteappp yspigddvql lptpsdrsry rldlegneyp ihstpnchdh ernhkvpppi kpkpvvpktn vkkldpnllk tieagigknp rkqtsrvpla hpedmdpsdn yaepidtifk qkgysdeiyv vpddsqnrik irnsfvnntq gdeengfsdr tskshgerrp skykyksktl fskaksyyrr thsdasddea fttsktkrkg rhrgseedpl lspvetwkgg idnpaitsdq elddkkmkkk thkvkedkkq kkktknfnpp trrnwesnYF GMPLQDLVTA EKPIPLFVEK CVEFIEDTGL CTEGLYRVSG NKTDQDNIQK QFDQDHNINL VSMEVTVNAV AGALKAFFAD LPDPLIPYSL HPELLEAAKI PDKTERLHAL KEIVKKFHPV NYDVFRYVIT HLNRVSQQHK INLMTADNLS ICFWPTLMRP DFENREFLST TKIHQSVVET FIQQCQFFFY NGEIVETtni vappppsnpg qlvepmvplq lppplqpqli qpqlqtdplg ii
JOB-ID: | Q13017_164047ZgWdj38AAAEAAFUIg2gAAABX |
---|---|
Paramters: | propensities=Russell/Linding smooth=10 dy/dx_smooth=10 |
Disorder frames: | peak-frame=5 join-frame=4 |
Globularity frames: | peak-frame=74 join-frame=15 |
Name: | Q13017 |
Description: | sp|Q13017|RHG05_HUMAN Rho GTPase-activating protein 5 OS=Homo sapiens OX=9606 GN=ARHGAP5 PE=1 SV=2 |
Plot title/ID: | none |
Sequence length: | 1502 |
Download Results | smoothed raw dydx |